Oscar Arrieta

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Oscar Arrieta
May 19, 2025, 19:28 | Insight
New Insights in ALK+ Lung Cancer Treatment: Promising Results From the ALEK-B trial - Oncogene Cancer Research
Oncogene Cancer Research shared on LinkedIn about a recent paper by Oscar Arrieta et al.…
May 19, 2025, 16:02 | Science
Yvonne Diaz: Combination of Alectinib and Bevacizumab Shows Promising Results in ALK+ NSCLC
Yvonne Diaz, EY Global Media Relations and Social Media Director, shared a post on X:…
May 17, 2025, 12:16 | Blog
Luis Lara-Mejía: Early Resistance in ALK+ NSCLC Targeted with Alectinib and Bevacizumab Combo
Luis Lara-Mejía, Medical Oncologist Specialized in Thoracic Neoplasms at National Institute of Cancerology, posted on…
May 17, 2025, 12:09 | Blog
Oscar Arrieta: Alectinib Plus Bevacizumab as First-Line Treatment in ALK-Rearranged NSCLC
Oscar Arrieta, Head of the Thoracic Oncology Unit at National institute of Oncology in Mexico,…
Feb 22, 2025, 14:43 | Blog
Giannis Mountzios: How active ADCs against oncogene-addicted NSCLC?
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Feb 18, 2025, 18:35 | Science
Giannis Mountzios: Biomarker-selected or biomarker-agnostic ADCs for oncogene-addicted NSCLC
Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant…
Feb 18, 2025, 10:44 | Science
Stephanie Saw: Our review paper on ADCs in NSCLC with AGA is out
Stephanie Saw, Medical Oncologist at National Cancer Center of Singapore, reshared a post by Giannis…
Jan 26, 2025, 12:08 | Science
Jordi Remon: De-Escalation strategies with immune checkpoint blockers in NSCLC
Jordi Remon, Thoracic oncologist at CIOCC Barcelona, shared a recent article by him and colleagues…
Nov 17, 2024, 04:27 | Blog
Highlights from the Latin American Lung Cancer Association 2024 Conference
The Annual Conference of the Latin American Lung Cancer Association (LALCA) took place from November 14…
Oct 16, 2024, 13:23 | Blog
Tackling global health inequities in lung cancer - EGFR Positive Lung Cancer UK
EGFR Positive Lung Cancer UK posted the following on X: “Lung cancer is challenging enough…
Oct 2, 2024, 15:14 | Blog
Suraj Samtani: Real-World Study of first Line Nivolumab plus Ipilimumab in Unresectable Pleural Mesothelioma
Suraj Samtani, Medical Oncologist at Harvard Medical School, shared a post on X, about recent…
Sep 26, 2024, 14:05 | Blog
Stephen V Liu: Real-world study of first-line nivolumab and ipilimumab for pleural mesothelioma
Stephen V Liu shared a post on X, about recent paper published in Clinical Lung…
Sep 10, 2024, 13:18 | Blog
Ana I. Velázquez Mañana: Dr Oscar Arrieta highlights efforts to increase cancer research and cancer care delivery in Mexico and LATAM
Ana I. Velázquez Mañana shared a post on X: "Dr Oscar Arrieta highlights efforts to…
Sep 10, 2024, 04:24 | Blog
Noemi Reguart: Dr. Oscar Arrieta's powerful talk in the opening ceremony at WCLC24
Noemi Reguart posted on X: "My friend and colleague Dr. Oscar Arrieta giving a powerfull…
Sep 9, 2024, 13:01 | Societies
Best of WCLC24 by Noemi Reguart
WCLC is a prominent global conference dedicated to the latest developments in lung cancer research,…
Sep 8, 2024, 13:51 | Societies
20 Posts Not To Miss from Day 1 of WCLC24
The International Association for the Study of Lung Cancer (IASLC) is a global, multidisciplinary organization…
Sep 2, 2024, 09:24 | Insight
Patrick R. Benusiglio: Pathogenic germline variants were identified in patients with lung cancer
Patrick R. Benusiglio, Associate Professor of Genetics (MCU-PH) and Head of Clinical Cancer Genetics at…
Jul 29, 2024, 23:25 | Blog
Lucia Viola: Un-meet in lung cancer screening, people who have never smoked
Lucia Viola, Interventional Pulmonologist and Head of Thoracic Oncology Service at Colombian Pulmonological Foundation, shared…
Jul 26, 2024, 10:41 | Opinion
Anyone with lungs can get lung cancer - LUNGevity Foundation
LUNGevity Foundation shared a post by Lucia Viola, Pulmonologist at Fundación Neumológica Colombiana, on X:…
Apr 11, 2024, 16:08 | Insight
New Paper Alert! Exploring the Genomic Diversity of Cancer in Latin American Populations
Exploring the Genomic Diversity of Cancer in Latin American Populations Authors: Alejandro Ruíz-Patiño, Leonardo Rojas,…
Apr 11, 2024, 07:21 | Blog
Luis E. Raez: Congratulations to Andres F. Cardona, Oscar Arrieta and their teams for this important publication
Luis E. Raez, Medical Director of Memorial Cancer Institute, shared a post on X/Twitter: ''Congratulations to…
Apr 5, 2024, 08:16 | Insight
Oscar Arrieta: Our study shows the impact on overall survival of integrating palliative care early in NSCLC patients
Oscar Arrieta, Head of the Thoracic Oncology Unit at National institute of Oncology in Mexico,…
Nov 29, 2023, 17:00 | Insight
Maite Bourlon: Access to novel drugs for metastatic renal cell carcinoma is an unmet need in the Mexican population
Maite Bourlon, Urology Oncologist at the National Institute of Medical Sciences and Nutrition Salvador Zubirán,…
Sep 30, 2023, 19:43 | Insight
Oscar Arrieta: Our study demonstrated that increased perilesional edema from brain metastases from NSCLC is a negative predictor of response to radiation therapy, short intracranial-PFS, and even worse OS.
Aug 31, 2023, 18:43 | Insight
Oscar Arrieta: We publish an update on the multidisciplinary management of TKI-induced diarrhea.
Oscar Arrieta, the Head of the Thoracic Oncology Unit and Personalized Medicine Laboratory, Instituto Nacional…
All: 25 Posts: 1 - 100
Special Coverage